Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Oklahoma Foundation for Digestive Research (OFDR) is a specialized clinical research organization and non-profit foundation based in Oklahoma City, Oklahoma. Established in 1990, the foundation focuses on advancing the understanding and treatment of gastrointestinal and liver disorders through Phase I-IV clinical trials. Led by Dr. Philip B. Miner, Jr., a prominent expert in inflammatory bowel disease and motility, OFDR operates a comprehensive research center that includes a specialized motility laboratory. The foundation collaborates with major pharmaceutical sponsors to evaluate novel therapies for conditions such as Crohn's disease, ulcerative colitis, and chronic constipation. By integrating clinical care with cutting-edge research, OFDR provides patients with access to emerging treatments while contributing significant data to the global medical community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oklahoma Foundation of Digestive Research.